Figure 7From: Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials Assessment of publication bias for PEG-IFNα+LAM combination therapy versus PEG-IFNα monotherapy on HBsAg clearance and HBsAg seroconversion (high-quality studies).Back to article page